Catch Your Insight
  • Investing
  • Tech News
  • Stock
  • World News
  • Editor’s Pick
Editor's PickInvesting

Pharmaceutical Pricing Around the World

by May 14, 2025
May 14, 2025

Peter Van Doren

Medicine Pharmacy

President Donald Trump recently issued an executive order about pharmaceutical prices. My colleague Michael Cannon has already written that the Department of Health and Human Services “does not have the power to ‘impose’ price controls on private pharmaceutical purchases.”

The order also instructed federal agencies to investigate why European countries pay lower prices for drugs. Why do drug prices vary across countries? An article in the Fall 2024 issue of Regulation offers some insight from economists.

The knowledge embodied in pharmaceuticals is a global public good. The incentives are for all countries to avoid the fixed costs of drug development and clinical trials and pay only the marginal costs of producing a drug. The demand for health care increases with income and population, so the worst-case possibility is that the richest and largest country (i.e., the US) pays all the fixed costs of drug development, and all other countries free ride and pay only the marginal costs.

The authors gathered data on sales revenue and compared the revenue to estimates of marginal cost to calculate each country’s contribution to the fixed costs of drug development. They conclude that a country’s GDP explains 83 percent of the variation in contributions across countries, and the effect of income is greater than proportional. A country with a 100 percent higher GDP contributes 129 percent more to pharmaceutical R&D. So, the US does contribute disproportionately to drug development costs. The rest of the world’s contribution is not zero but is less than would be predicted by income and population alone.

The authors conclude: “Our findings indicate prospective gains from international cooperation–from formal or informal international agreements among high-income countries. If other wealthy countries agreed to contribute more to the global public good, they, and the world, would benefit.”

previous post
How to Use Relative Strength in a Volatile Market
next post
Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

You may also like

Tech Stocks Lead the Charge: What’s Driving the...

July 1, 2025

CAFE Standards

June 30, 2025

Ellingburg v. United States Brief: Criminal Restitution Counts...

June 30, 2025

This Harm Reduction Innovation Is Already Saving Lives

June 30, 2025

Fifteen Minutes on ICE’s Mass Deportation Agenda

June 30, 2025

Is This Rally Sustainable? You Better Bet Your...

June 30, 2025

Pullbacks & Reversals: Stocks Setting Up for Big...

June 30, 2025

Senate Big Beautiful Bill: More Growth, More Subsidies,...

June 30, 2025

One Big Bloated Blunder: What’s Wrong with the...

June 30, 2025

Bank Secrecy Act and Capital Gains Targeted for...

June 30, 2025

    Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Tech Stocks Lead the Charge: What’s Driving the Momentum?

      July 1, 2025
    • CAFE Standards

      June 30, 2025
    • Ellingburg v. United States Brief: Criminal Restitution Counts as Criminal Punishment

      June 30, 2025
    • This Harm Reduction Innovation Is Already Saving Lives

      June 30, 2025
    • Fifteen Minutes on ICE’s Mass Deportation Agenda

      June 30, 2025
    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 catchyourinsight.com | All Rights Reserved

    Catch Your Insight
    • Investing
    • Tech News
    • Stock
    • World News
    • Editor’s Pick